Publication | Closed Access

Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination

Hematological MalignancyChronic Myeloid LeukemiaNon-myeloablative Drug CombinationTransplantationMarrow TransplantationMedicineMixed-phenotype Acute LeukemiaHematologyPharmacologyCell Replacement TherapyPharmacotherapyTransplant-related ComplicationsOncologyCell TransplantationMyeloid Neoplasia